عرض سجل المادة البسيط

Seroprevalence of Rubella Virus Antibodies and Antibody Titer Among Childbearing Aged Women

dc.contributor.authorAlferjani, Yasmin Haleem
dc.contributor.authorAldanini, Thuraya Faisal
dc.contributor.authorMansur, Khadija Muftah Hilal
dc.date.accessioned2026-01-04T20:50:06Z
dc.date.available2026-01-04T20:50:06Z
dc.date.issued2025-04-26
dc.identifier.citationAlferjani YH, Aldanini TF, Mansur KMH. Seroprevalence of Rubella Virus Antibodies and Antibody Titer Among Childbearing Aged Women. Journal of The Best Available Evidence in Medicine. 2025;1(1):22-25. doi:10.63720/hb7id669en_US
dc.identifier.issn2978-0489
dc.identifier.otherDOI: 10.63720/hb7id669
dc.identifier.urihttp://dr.limu.edu.ly/handle/123456789/5000
dc.description.abstractBACKGROUND Rubella virus is the sole member of the Rubivirus genus in the Matonaviridae family, previously classified under the Togaviridae family, that causes German measles. Humans are the only natural hosts for this virus. The virus is transmitted via respiratory droplets, and starts replication in nasopharyngeal lymphoid tissue, and then spreads to regional lymph nodes. Despite the significant decline of cases globally, rubella remains a global health concern, especially in regions such as Africa, East Asia, and South Asia. The aim of this research is to provide new data for the seroprevalence of rubella antibodies and antibody titers among childbearing aged women studying or working at the Libyan International University, and to assess the need for a booster dose of MMR vaccine. METHODS AND MATERIALS A cross-sectional, observational, descriptive study was conducted to assess the seroprevalence of rubella virus-specific antibodies and antibody titers in the serum of 166 women of child-bearing age (16-45 years) using chemiluminescent immunoassay. The samples were collected using a convenience sampling approach. Statistical analyses were performed using a chi-square test and the Statistical Package for the Social Sciences (SPSS) software. RESULTS The overall seroprevalence of rubella-specific IgG-positive antibodies was 86.7%, while 6% were IgG-negative and 7.2% were IgG-equivocal. Seroprevalence increased with age, reaching 100% in the 36-45 years age group. Only 0.6% were positive for rubella-specific IgM antibodies. CONCLUSION These findings suggest relatively high immunity against rubella in this population, though a significant proportion remain unprotected. This may guide decision makers regarding implementation of relevant public health strategies and vaccination programs.en_US
dc.language.isoenen_US
dc.publisherOpen Science Pressen_US
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.subjectRubella virusen_US
dc.subjectSeroprevalence Congenital Rubella Syndromeen_US
dc.subjectGestationen_US
dc.subjectTORCHen_US
dc.subjectInfectionen_US
dc.subjectVaccinationen_US
dc.subjectMeasles-rubella vaccine MMR vaccineen_US
dc.subjectBenghazien_US
dc.titleSeroprevalence of Rubella Virus Antibodies and Antibody Titer Among Childbearing Aged Womenen_US
dc.typeArticleen_US


الملفات في هذه المادة

Thumbnail
Thumbnail

هذه المادة تظهر في الحاويات التالية

عرض سجل المادة البسيط

Attribution-NonCommercial 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial 3.0 United States